| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |